Sept 11 (Reuters) - Kane Biotech Inc KNE.V :
* KANE BIOTECH ANNOUNCES DEPARTURE OF CEO
* KANE BIOTECH INC - MARK AHRENS-TOWNSEND HAS DEPARTED FROM COMPANY AS CHIEF EXECUTIVE OFFICER AS OF SEPT 10, 2018
* KANE BIOTECH INC - MARK AHRENS-TOWNSEND WILL REMAIN CLOSE TO COMPANY AND CONTINUE TO WORK AS AN ADVISOR
* KANE BIOTECH INC - MARC EDWARDS, DIRECTOR OF KANE BIOTECH, IS APPOINTED AS INTERIM CEO IN ADDITION TO HIS CURRENT POSITION